Showing 17,361 - 17,380 results of 28,927 for search '(( 5 step decrease ) OR ( 50 ((((ms decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 0.88s Refine Results
  1. 17361

    DNA damage evoked by <i>K. pneumoniae</i> 1084 infection <i>in vivo</i>. by Yi-Chyi Lai (213766)

    Published 2014
    “…An asterisk (*) represents a significant decrease in the Δ<i>clbA</i>-infected group in comparison with the <i>K. pneumoniae</i> 1084-infected group by the Mann-Whitney U test (two-tailed; <i>P</i><0.05). …”
  2. 17362
  3. 17363

    Standardized mean effect differences between wet-lab experiment and model simulations. by Rachael Miller Neilan (10678614)

    Published 2021
    “…Positive Hedges’ <i>g</i> is indicative of an increase in pain-like effect for the indicated comparison and a negative Hedges’ <i>g</i> is indicative of a decrease in pain-like effects. …”
  4. 17364
  5. 17365

    BPLF1 selectively inhibits the detection of TOP2-induced DNA damage. by Jinlin Li (2267896)

    Published 2021
    “…The expression of catalytically active BPLF1 was associated with a significant decrease of Etoposide induced nuclear γH2AX fluorescence and decreased formation of 53BP1 foci. …”
  6. 17366
  7. 17367
  8. 17368
  9. 17369

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  10. 17370
  11. 17371

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
  12. 17372
  13. 17373
  14. 17374
  15. 17375
  16. 17376
  17. 17377
  18. 17378
  19. 17379
  20. 17380